Anaptysbio Inc (ANAB)
$48.28 -0.74% Close Oct 30, 2026 Live
Anaptysbio stock today
Anaptysbio closed at $48.28 on October 30, 2026, down 0.74% on the day. Over the past year it returned +98.6% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $1.41 billion.
$20.00$40.00$60.00
NovJan 2026MarMayJulSep
| Period | ANAB | S&P 500 (SPY) |
|---|---|---|
| 1 month | -3.9% | -0.9% |
| 3 months | -12.3% | +2.1% |
| Year to date | +49.4% | +11.7% |
| 1 year | +98.6% | +12.4% |
| 3 years | +339.2% | +88.5% |
| 5 years | +120.1% | +76.0% |
Key statistics
- Market value
- $1.41B
- Forward P/E
- 10.8
- Price / sales
- 5.9
- 52-week range
- $22.06 to $69.81
- Next report
- Nov 3, 2026 (estimated)
About Anaptysbio
Anaptysbio discovers and develops biologics for immunology and inflammatory diseases.
Sector: Health Care
More on Anaptysbio
- Financials: revenue, earnings and segmentsRevenue +157% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $2,201 today
No forecast, no recommendation. This page describes Anaptysbio Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.